Pharma Mar SA (PHMMF)
94.60
0.00 (0.00%)
USD |
OTCM |
Oct 07, 16:00
Pharma Mar Profit Margin (Quarterly) : -1.96% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.96% |
| March 31, 2026 | 3.57% |
| December 31, 2025 | 65.95% |
| September 30, 2025 | -11.50% |
| June 30, 2025 | 41.44% |
| March 31, 2025 | -10.16% |
| December 31, 2024 | 38.63% |
| September 30, 2024 | 8.55% |
| June 30, 2024 | 2.89% |
| March 31, 2024 | 6.06% |
| December 31, 2023 | -16.83% |
| September 30, 2023 | 4.06% |
| June 30, 2023 | 10.87% |
| March 31, 2023 | 4.15% |
| December 31, 2022 | 2.53% |
| June 30, 2022 | 26.84% |
| March 31, 2022 | 41.32% |
| December 31, 2021 | 39.90% |
| September 30, 2021 | 25.41% |
| June 30, 2021 | 40.11% |
| March 31, 2021 | 47.17% |
| December 31, 2020 | 12.90% |
| September 30, 2020 | 32.62% |
| June 30, 2020 | 62.05% |
| March 31, 2020 | 70.96% |
| Date | Value |
|---|---|
| December 31, 2019 | 66.77% |
| September 30, 2019 | -26.86% |
| June 30, 2019 | -39.49% |
| March 31, 2019 | -53.69% |
| December 31, 2018 | -15.52% |
| September 30, 2018 | -64.94% |
| June 30, 2018 | 7.87% |
| March 31, 2018 | -9.01% |
| December 31, 2017 | -34.54% |
| September 30, 2017 | -16.16% |
| June 30, 2017 | -9.69% |
| March 31, 2017 | -5.42% |
| December 31, 2016 | -18.14% |
| September 30, 2016 | -7.20% |
| June 30, 2016 | -12.11% |
| March 31, 2016 | -16.93% |
| December 31, 2015 | -1.62% |
| September 30, 2015 | 10.31% |
| June 30, 2015 | -6.45% |
| March 31, 2015 | 18.74% |
| December 31, 2014 | -13.51% |
| September 30, 2014 | 1.86% |
| June 30, 2014 | -0.24% |
| March 31, 2014 | 49.63% |
| December 31, 2013 | -7.99% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Oryzon Genomics SA | -- |
| Grifols SA | 9.77% |
| ACADIA Pharmaceuticals, Inc. | 10.23% |
| Alkermes Plc | 0.10% |
| Alnylam Pharmaceuticals, Inc. | 12.74% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 24.39% |
| Return on Assets | 15.06% |
| Return on Invested Capital | 20.12% |
| Gross Profit Margin (Quarterly) | 86.21% |
| Operating Margin (Quarterly) | -4.23% |
| Return on Net Operating Assets | 35.07% |